Zelnorm lawsuits are now being reviewed

Zelnorm (generic tegaserod maleate) has been linked to an increased risk of heart attacks, strokes and other potentially life-threatening injuries.  Last week the FDA requested that the Novartis Pharmaceutical Corporation halt sales of the drug for treatment of irritable bowel syndrome since the dangers associated with… Read More

Austin Kirk

By
April 6, 2007 | 4 Comments

Side effects of Permax & Dostinex reviewed

The drug recall lawyers at Saiontz & Kirk are investigating potential Permax lawsuits and Dostinex lawsuits for users who suffered serious injury or death after using one of the drugs for management of Parkinson's disease symptoms. >>INFORMATION: Permax side effects (more…) Read More

Austin Kirk

By
April 2, 2007 | No Comments

Actiq lollipop is a part of Congressional inquiry

The makers of the Actiq lollipop pain medication are one of five pharmaceutical companies who received a letter from U.S. Congress Rep. Henry A. Waxman earlier this month, as part of his investigation into inappropriate marketing and incomplete research regarding drugs and medical devices.  In recent… Read More

Harvey Kirk

By
March 26, 2007 | 5 Comments

FDA warns of sleeping pill side effects

The FDA announced that new warnings will be added to Ambien, Lunesta and other popular sleeping pills, containing information about an increased risk of sleep driving and other complex behaviors while asleep.  Potential sleeping pill side effects will also be outlined by drug makers in information… Read More

Harvey Kirk

By
March 18, 2007 | No Comments

Vioxx lawsuit verdict $47.5 million

Today a New Jersey jury awarded $47.5 million in a Vioxx lawsuit filed after the popular pain killer caused a heart attack for an Idaho postal worker.  The jury found that Vioxx caused the Plaintiff's heart attack and that the drug maker acted in a fraudulent… Read More

Donald Saiontz

By
March 13, 2007 | No Comments

Fosamax lawsuits are getting Merck’s attention

Fosamax lawsuits are pending in courts across the country for users of the popular osteoporosis drug who have suffered serious jaw side effects.  Recently Merck, the maker of Fosamax, announced that they have set aside nearly $50 million dollars to cover the initial defense costs associated… Read More

Austin Kirk

By
February 25, 2007 | 4 Comments